Table 1.
No. | Reference | Publication year | Sex | Age(years) | Symptoms and signs | Laboratory findings | Location | Size (cm) | Surgery | Adjuvant therapy | Recurrence | Follow-up, duration | Co-morbidity or past history |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
Mattila et al. [4] |
1974 |
F |
68 |
RUQA pain, hepatomegaly |
↑ALP, LDH, Bilirubin |
R + L |
20 × 18 × 15 |
Rx ext hep |
None |
Yes |
DOD, 5 months |
None |
2 |
Tanner et al. [5] |
1978 |
F |
66 |
RUQA pain, vomiting, diarrhea, weight loss, fever, hepatomegaly |
↑ALP, GGT |
R |
NA |
HA ligation + pump |
5-FU |
- |
AWD, 8 months |
CHD |
3 |
Chang et al. [6] |
1983 |
F |
55 |
RUQA pain, weight loss, diarrhea, hepatomegaly |
↑ALP |
L |
10 × 10 × 8 |
Left lob |
CAV |
No |
ANED, 12 months |
CREST syndrome |
4 |
Ellis et al. [7] |
1983 |
F |
86 |
RUQA pain, RUQA mass |
Normal |
R |
18 × 12 × 12 |
Tumorectomy |
None |
Yes |
DOD, 2 months |
None |
5 |
Forbes et al. [8] |
1987 |
M |
69 |
RUQA pain, nausea, weight loss, general malaise |
Normal |
NA |
NA |
None |
RT |
- |
DOD, 10 months |
Malaria and resection for colonic carcinoma |
6 |
Forbes et al. [8] |
1987 |
F |
49 |
RUQA pain, nausea, weight loss, general malaise |
NA |
NA |
NA |
None |
None |
- |
DOD |
None |
7 |
Grazi et al. [9] |
1996 |
F |
60 |
RUQA mass, dyspepsia |
Normal |
R |
22 |
Rx hep |
None |
Yes |
DOD, 10 months |
NA |
8 |
Nishio et al.[3] |
2003 |
F |
49 |
RUQA pain, general fatigue |
NA |
R |
14 × 8 × 8 |
Rx lob |
Adm + Dtic |
Yes |
DOD, 29 months |
None |
9 |
Nishio et al. [3] |
2003 |
M |
62 |
RUQA pain |
NA |
L |
10 × 9 × 7 |
Left lob |
None |
No |
ANED, 10 months |
NA |
10 |
Lepreux et al. [10] |
2005 |
F |
51 |
RUQA pain, dyspnea, edema of the lower limbs |
Normal |
R |
18 × 16 |
Liver biopsy |
CAV |
NA |
DOD, 2 months (died from septic shock and acute pneumopathy) |
NA |
11 |
Lepreux et al. [10] |
2005 |
F |
49 |
RUQA pain, increased abdominal girth |
Normal |
L |
15 × 13 |
Left lob |
MAID, RT |
No |
ANED, 6 months |
NA |
12 |
Agaram et al. [11] |
2006 |
F |
50 |
NA |
NA |
NA |
17 |
NA |
NA |
No |
ANED, 8 months |
NA |
13 |
Scudiere et al. [12] |
2006 |
F |
51 |
NA |
↑ALT, AST |
R |
23 × 16 × 7 |
Rx lob |
NA |
NA |
NA |
Community-acquired pneumonia |
14 |
Ma et al. [13] |
2008 |
F |
61 |
RUQA pain |
Normal |
R |
12 × 9 × 8 |
Rx hep |
None |
NA |
DOD, 8 months |
None |
15 |
Yang et al. [14] |
2009 |
M |
46 |
Upper abdominal pain, fever, mass, hepatomegaly |
↑ALT, GGT, AFP HBeAb(+), HBcAb(+) |
R |
6 × 6 × 5 |
Rx hep |
NA |
NA |
NA |
Hepatitis B cirrhosis and HCC in the left lobe |
16 |
Yang et al. [14] |
2009 |
M |
54 |
Upper abdominal pain, fever, mass, hepatomegaly |
↑ALT, AST, GGT |
R |
13 × 12 × 12 |
Rx hep |
NA |
NA |
NA |
None |
17 |
Kullar et al. [15] |
2009 |
F |
52 |
RUQA pain, RUQA mass |
↑ALP |
R |
18 × 12 × 8 |
Rx ext hep |
Adm + Ifs |
Yes |
DOD, 12 months |
Chemotherapy for ovarian cancer |
18 |
Yoon et al. [16] |
2010 |
F |
53 |
Abdominal discomfort |
Normal |
R |
13 × 12 × 8 |
Rx hep |
None |
No |
ANED, 6 months |
None |
19 |
Massani et al. [17] |
2010 |
F |
47 |
Upper abdominal pain |
Normal |
R |
8 |
Rx hep |
Epi + Ifs; TACE with Epi |
Yes |
AWD, 29 months |
None |
20 |
Li et al. [18] |
2010 |
M |
63 |
RUQA pain, fever |
↑ALP |
R |
20 × 15 × 15 |
Rx hep |
NA |
Yes |
DOD, 18 months |
None |
21 |
Li et al. [18] |
2010 |
M |
56 |
RUQA pain |
↑ALP, ALT, AST, GGT |
R |
13 × 12 |
Rx hep |
TACE with lipiodol, Epi, hydroxycamptothecin |
Yes |
DOD, 28 months |
None |
22 |
Gasljevic et al. [19] |
2011 |
F |
58 |
Asymptomatic |
NA |
R |
11 × 8 |
Rx lob |
Cysplatin + 5-FU + Vcr |
No |
DOD, 10 months (died from unrelated cause, B-ALL) |
None |
23 |
Kim et al. [20] |
2011 |
F |
47 |
Abdominal mass |
↑CA-125 |
L |
12 × 10 |
Left hep |
MAID, RT |
Yes |
AWD, 48 months |
None |
24 |
Legou et al. [21] |
2012 |
F |
61 |
Upper abdominal pain, RUQA mass |
↑ALP, ALT, AST |
L |
27 × 22 × 10 |
Tumorectomy |
NA |
NA |
NA |
None |
25 |
Tanaka et al. [22] |
2012 |
F |
53 |
Asymptomatic |
Liver function tests were slightly abnormal |
R |
12 × 11 × 7 |
Rx lob |
None |
Yes |
DOD, 36 months |
Multiple sclerosis |
26 |
Tucker et al. [23] |
2012 |
F |
74 |
Abdominal pain and fullness, back pain |
Normal |
L |
18 × 15 × 13 |
Left hep |
None |
No |
ANED, 9 months |
NA |
27 |
Lightfood et al. [24] |
2012 |
F |
78 |
Abdominal mass |
Normal |
R |
16 |
Partial right hepatectomy |
None |
No |
ANED, 6 months |
NA |
28 | This report | 2013 | F | 49 | Upper abdominal pain | Normal | R | 7 × 6 × 5 | Rx lob | Traditional Chinese medicine orally | Yes | DOD, 12 months | SLE |
5-FU, 5-fluouracil; Adm, doxorubicin; AFP, α-fetoprotein; ALP, alkaline phosphatase; ALT, alanine aminotransferase; ANED, alive with no evidence of disease; AST, aspartate aminotransferase; AWD, alive with disease; B-ALL, B-lymphoblastic leukemia; CA-125, carbohydrate antigen 125; CAV, cyclophosphamide + Adm + Vcr; CHD, coronary heart of disease; CREST syndrome, calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia syndrome; DOD, dead of disease-related cause; Dtic, decarbazine; Epi, epirubicin; F, female; GGT, γ-glutamyl transpeptidase; HA, hepatic artery; HCC, hepatocellular carcinoma; Ifs, ifosfamide; L, left; Left hep, left hepatectomy; Left lob, left lobectomy; M, male; MAID, Adm + Ifs + Dtic + methylprednisolone; NA, not available; R, right; RT, radiation therapy; RUQA, right upper quadrant abdominal; Rx ext hep, extended right hepatectomy; Rx hep, right hepatectomy; Rx lob, right lobectomy; SLE, systemic lupus erythematosus; TACE, transcatheter arterial chemoembolization; Vcr, vincristine.